Hematology/Oncology
Rikhi R, Haidar A, Bhatia HS, Beam K, McParland J, Kazibwe R, Chevli P, Schaich CL, Sanghavi M, Shapiro MD. Association of lipoprotein(a) and diabetes[...]
Mesa R, Yacoub A, Tashi T, Chai-Ho W, Yoon CH, Mascarenhas J. Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b.[...]
Bandos H, Kim S, Henry NL, Hays RD, Calsavara VF, Luu M, Gresham G, Lu KY, Irvin WJ, Suga JM, Siddique S, Cecchini RS, Rogatko[...]
Marshalek JP, Qing X, Tomassetti S. CD19 Expression in B-Cell Lymphomas and Clinical Considerations in the Evolving Landscape of CD19-Targeted Therapy. World J Oncol. 2025[...]
Hecht JR, Oberoi A, Garralda Cabanas E, Jae Chon H, Digklia A, Rottey S, Martin Jimenez M, Chaney M, Hippenmeyer J, Lawrence T, Liu K,[...]
Duggirala N, Zhang S, Master A, Rao R, Kapoor NS, Bardia A, Lipsyc-Sharf M. Biology, care, and outcomes of gestational breast cancers: a review. Breast[...]
Yoo C, Ueno M, Klümpen HJ, Kelley RK, Vogel A, Furuse J, Ren Z, Yau T, Chan SL, Ozaka M, Oh SC, Gu S, Park[...]
Bransky NP, Kathuria-Prakash N, Sehl M. CRE25-032: Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma. J Natl Compr Canc Netw. 2025 Mar 28;23(3.5):CRE25-032. doi: 10.6004/jnccn.2024.7101. PMID: 40154331.
Huynh JT, Li R, Shin DS. CRE25-050: Durable Response to Immunotherapy Rechallenge With Double Immunotherapy for a Patient With Advanced Non-Small Cell Lung Cancer. J[...]
Bardia A, Pistilli B, Rugo H. Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer. J Clin Oncol. 2025 Mar 28:JCO2402833.[...]